Roche’s PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH Read more
UCB to Accelerate Innovation and Strategic Partnerships, Divesting Mature Product Portfolio in China Read more
ENHERTU Granted Breakthrough Therapy Designation in U.S. for Certain Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Read more
Incyte and Syndax Announce FDA Approval of Niktimvo (axatilimab-csfr) for the Treatment of Chronic Graft-Versus-Host Disease (GVHD) Read more